Magnolia Medical Technologies

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

1. ComplianceBetween 19 July 2019 and 22 July 2020

   Now states FDA CLEARED and FDA-CLEARED compliance on its homepage.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
2. HeadlineBetween 8 January 2018 and 19 July 2019

   BeforeBECAUSE ACCURACY MATTERS

   AfterInitial Specimen Diversion Device®

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
3. HiringBetween 5 February 2016 and 8 January 2018

   Added a careers page.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

1. August 2023 – November 2026 · 4 captures · latest observed messagingWe Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero

   Magnolia Medical Technologies, proud makers of the Steripath Micro Initial Specimen Diversion Device for blood culture testing integrity.

   This wording observed 6 November 2026.

   current websiteHistorical capture not publicly available
   Inspect 4 captures in this group

   • 23 August 2023 · We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero archived page
   • 11 July 2024 · We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero archived page
   • 15 January 2026 · We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero archived page
   • 6 November 2026 · We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero current websiteHistorical capture not publicly available
2. July 2020 – January 2022 · 2 capturesMagnolia Medical Technologies I Makers of Steripath®

   Magnolia Medical Technologies, proud makers of the Steripath Initial Specimen Diversion Device for blood culture testing integrity.

   This wording observed 3 January 2022.

   archived page
   Inspect 2 captures in this group

   • 22 July 2020 · Steripath by Magnolia Medical Technologies archived page
   • 3 January 2022 · Magnolia Medical Technologies I Makers of Steripath® archived page
3. Seen July 2019 · 1 captureInitial Specimen Diversion Device®

   Steripath, by Magnolia Medical Technologies, is a proven solution to significantly reduce blood culture contamination and false-positive results for sepsis.

   This wording observed 19 July 2019.

   archived page
4. Seen January 2018 · 1 captureBECAUSE ACCURACY MATTERS

   The SteriPath by Magnolia Medical Technologies is a proven solution to significantly reduce blood culture contamination.

   This wording observed 8 January 2018.

   archived page
5. March 2015 – February 2016 · 2 capturesMagnolia Medical

   This wording observed 5 February 2016.

   archived page
   Inspect 2 captures in this group

   • 29 March 2015 · Magnolia Medical archived page
   • 5 February 2016 · Magnolia Medical archived page
6. Seen March 2013 · 1 captureReduce blood culture contamination using the Initial Specimen Diversion Device.

   This wording observed 3 March 2013.

   archived page

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• Lo Bio lo-bio.comPartial overlapBoth offer blood collection devices that improve downstream diagnostic sample integrity.